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This study was conducted to investigate whether agmatine (AGM) provides protection against oxidative stress induced by treatment with 
chlorpromazine (CPZ) in Wistar rats. In addition, the role of reactive oxygen species and efficiency of antioxidant protection in the brain 
homogenates of forebrain cortexes prepared 48 h after treatment were investigated. Chlorpromazine was applied intraperitoneally (i.p.) in 
single dose of 38.7 mg/kg body weight (BW) The second group was treated with both CPZ and AGM (75 mg/kg BW). The control group 
was treated with 0.9% saline solution in the same manner. All tested compounds were administered i.p. in a single dose. Rats were sacrificed 
by decapitation 48 h after treatment Treatment with AGM significantly attenuated the oxidative stress parameters and restored antioxidant 
capacity in the forebrain cortex. The data indicated that i.p. administered AGM exerted antioxidant action in CPZ-treated animals. Moreover, 
reactive astrocytes and microglia may contribute to secondary nerve-cell damage and participate in the balance of destructive vs. protective 
actions involved in the pathogenesis after poisoning.
Keywords: agmatine, antioxidant defense, astrocytes, chlorpromazine, oxidative stress
Introduction
Chlorpromazine (CPZ) has long been used in clinical practice 
as an antipsychotic drug [26,31]. The therapeutic effects of CPZ 
act via inhibition of calcium-(Ca2+)-dependent phospholipase 
A2 and are believed to occur via binding to calmodulin 
(Ca2+-binding messenger protein) [14]. Excessive stimulation 
of Ca2+-activated processes, such as those catalyzed by 
nonlysosomal proteases, endonucleases and phospholipases, 
may be the predominant cytotoxic event for a variety of toxic 
insults [28]. 
Oxidative stress and products of lipid peroxidation (LPO) are 
implicated in the pathophysiology of various neurological 
disorders. Chronic treatment with neuroleptics increases free 
radical production and oxidative stress [5]. Generation of 
reactive oxygen species (ROS) and reactive nitrogen species is 
known to damage various cellular components and thereby 
contribute to cellular dysfunction [33]. The products of LPO 
react with residues on amino acids such as cysteine or lysine and 
disturb protein function. It is well known that antipsychotics 
increase oxidative stress by altering the activity of antioxidant 
enzymes and causing oxidative damage, particularly LPO in the 
brain [30]. Antioxidant defense (AOS) mechanisms play the 
primary role in tissue repair and include enzymes that scavenge 
ROS (superoxide dismutase [SOD], catalase [CAT], glutathione 
peroxidase [GPx], glutathione reductase [GR]), but also 
nonenzymatic biomolecules (glutathione [GSH]). 
In addition to a number of important physiological properties 
related to central nerve system (CNS) homeostasis, astrocytes 
are involved in regulation of the brain microenvironment. 
Activation of microglial and astroglial cells is a sensitive 
marker of the pathological processes occuring in the cellular 
microenvironment of the CNS [24].
Since CPZ induces oxidative stress by activating various 
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reactive species that lead to tissue damage, our the study pointed 
to the potentially protective effect of (4-aminobutyl) guanidine, 
agmatine (AGM) and its ability to correct changes in indicators 
of oxidative/nitrosative stress induced by CPZ. AGM is the 
decarboxylation product of arginine and an intermediate in 
polyamine biosynthesis [35]. It is well known that AGM is a 
putative neurotransmitter synthesized in the brain, stored in 
synaptic vesicles, accumulated by uptake, released by membrane 
depolarization, and inactivated by agmatinase [32]. 
Based on this background, this study was conducted to 
investigate the role of ROS, efficiency of antioxidant protection, 
and importance of glial activation in the rat forebrain cortex 48 
h after acute CPZ and AGM administration. 
Materials and Methods
Animals
Experimental animals were treated according to the Guidelines 
for Animal Study, No. 282-12/2002 (Ethics Committee of the 
Military Medical Academy, Belgrade, Serbia and Montenegro). 
The experiments were performed on adult male Wistar rats 
weighing approximately 230 g that had been randomly divided 
into four groups. All animals were housed in cages under 
standardized conditions (ambient temperature of 23 2oC with 
55 10% humidity and a light/dark cycle of 13/11 h). The rats 
were given a commercial rat diet and tap water ad libitum.
Experimental procedure
The experiment consisted of four experimental groups of 10 
rats each that received the following: normal saline 
intraperitoneally (i.p.) as a control (CG group); a single daily 
dose (38.7 mg/kg body weight [BW] i.p.) of CPZ-HCl (Medisca, 
Italy) (CPZ group); 38.7 mg/kg BW CPZ-HCl i.p. followed by 
75 mg/kg BW i.p. daily doses of AGM (CPZ+AGM group); and 
a single daily dose (75 mg/kg BW) of AGM i.p. (AGM group). 
Animals were sacrificed by decapitation at 48 h after the 
appropriate treatment, after which the brain was excised and 
stored at −20oC.
Determination of CPZ concentration
The concentration of CPZ was determined by high performance 
liquid chromatography-tandem mass spectrometry (HPLC 
MS/MS) [19]. Briefly, 4 mL of acidic acetonitrile was added to 
1 g of brain tissue and homogenized using an T18 digital 
ULTRA-TURRAX (IKA-Werke, Germany) homogenizer, then 
centrifuged for 10 min at 1,372 × g. Subsequently 6 mL of a 
10% NaCl solution added to the supernatant. The samples were 
then purified on a C-18 column that had been preconditioned 
with 5 mL of methanol, folowed by 5 mL of water. After the 
sample extract was loaded onto conditioned SPE colums and 
passed trough, the columns were washed with 1 mL 0.01 M 
H2SO4. CPZ was then eluted from the columns with a 2 × 3 mL 
mixture of acidic acetonitrile and methanol (50：50) eluate and 
evaporated under a nitrogen stream, after which the residue was 
dissolved in 1 mL of acidic acetonitrile and methanol (50：50). 
The method was performed on an HPLC MS/MS Waters 
Acquity with TQD detector using a stock standard solution of 
CPZ prepared in methanol (concentration 0.897 mg/mL) and 
standard working solutions prepared by diluting the stock 
standard solution in the mobile phase. 
Biochemical analyses 
The forebrain cortex was dissected on ice, after which each 
tissue slice (approximately 0.1 g) was transferred separately 
into cold, buffered sucrose (0.25 M/L sucrose, 0.1 mM/L 
ethylenediaminetetraacetic acid [EDTA] in sodium-potassium 
phosphate buffer, pH 7.2). Aliquots (1 mL) were placed into a 
glass tube homogenizer (Tehnica Zelezniki Manufacturing, 
Slovenia) with a Teflon pestle at 1,000 × g for 15 min at 4oC. The 
supernatant was then centrifuged at 2,500 × g for 30 min at 4oC. 
The resulting precipitate was suspended in 1.5 mL of deionized 
water. Subcellular membranes were solubilized in hypotonic 
solution by constant mixing for 1h using a Pasteur pipette. 
Thereafter, homogenates were centrifuged at 2,000 × g for 15 
min at 4oC and the resulting supernatant was used for analysis 
[17]. The total protein concentration was estimated with bovine 
serum albumin as a standard [23]. 
Lipid peroxidation in the forebrain cortex was measured as 
tiobarbituric acid reactive substances production (TBARS) 
using the method described by Girotti et al. [15]. Data were 
expressed as nmol/mg proteins. Superoxide anion (O2•−) 
content was determined by the reduction of nitroblue- 
tetrazolium in alkaline nitrogen saturated medium. Kinetic 
analysis was performed at 550 nm [4]. The results were 
expressed as nmol red nitro blue tetrazolium/min/mg proteins.
Total GSH (GSH + 1/2 GSSG, in GSH equivalents) content 
was determined using a DTNB-GSSG reductase recycling 
assay. The rate of formation of 5-thio-2-nitrobenzoic acid 
(TNB), which is proportional to the total GSH concentration, 
was followed spectrophotometrically at 412 nm [2]. The results 
were expressed as nmol/mg proteins. 
SOD (EC 1.15.1.1.) activity was measured 
spectrophotometrically as the inhibition of epinephrine 
spontaneous auto-oxidation at 480 nm. The kinetics of sample 
enzyme activity was followed in a carbonate buffer (50 mM, pH 
10.2) containing 0.1 mM EDTA after the addition of 10 mM 
epinephrine [39].
Catalase activity was determined by the spectrophotometric 
method. Ammonium molybdate forms a yellow complex with 
H2O2 and is suitable for measuring both serum and CAT activity 
in the tissue [16]. Kinetic analysis was performed at 405 nm. 
CAT activity was defined as mol H2O2 reduced per minute 
(mol H2O2/min). Data were expressed as U/mg proteins.
A ransel kit for the determination of GPx (Randox 
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Laboratories, USA) was used to indirectly measure the activity 
of GPx [40]. The oxidation of NADPH to NADP+ is associated 
with a decrease in absorbance at 340 nm. Enzyme activity of 
GPx was defined as mol NADPH oxidized per minute (mol 
NADPH/min) and the results were expressed as U/mg proteins.
The method for determining the activity of the GR is based on 
the ability of GR to catalyze the reduction of GSSG to GSH by 
oxidation of the coenzyme NADPH to NADP+ [13]. In the 
reaction, we used 100 mmol NAD+ as a standard. Enzyme 
activity was defined as µmol NADPH oxidized per minute 
(mol NADPH). The results were expressed as U/mg proteins.
Reagents
All chemicals used in this study were of analytical grade. 
DTNB, NaH2PO4, ammonium molybdate, ammonium acetate, 
NADPH and NADH were purchased from Merck (Germany). 
Na2HPO4 × 2H2O, TCA, nitroblue-tetrazolium, gelatin, Na2CO3, 
NaHCO3, epinephrine, EDTA, NAD+, methanol and GSSG 
(oxidized form) were purchased from Serva-Feinbiochemica 
(USA). TBA was purchased from ICN Biomedicals (Ohio) and 
acetonitrile was purchased from Backer J.T., Deventer (the 
Netherlands). GSH reductase (EC 1.6.4.2; Type III, from yeast 
[9001-48-3]) and analytical standard for CPZ (catalog No. 
C8138) were purchased from Sigma-Aldrich (USA). Saline 
solution (0.9% w/v) was purchased by the Hospital Pharmacy 
(Military Medical Academy, Belgrade, Serbia). All drugs 
solutions were prepared on the day of the experiment.
Immunohistochemistry
For immunohistochemical analyses, brains (four per group) 
were quickly removed and fixed in 4% paraformaldehyde in 0.1 
M phosphate buffer (PBS) at pH 7.4 for 12 h at 4oC. For 
cryoprotection, brain tissue was transferred into the graded 
sucrose (10–30% in 0.1 M PBS, pH 7.4). The brains were frozen 
in 2-methyl butane and kept at −80oC until sectioning on a 
cryotome. Coronal sections (25 m thick) were collected 
serially, mounted on superfrost glass slides, dried for 2 h at room 
temperature and stored at −20oC until staining. Subsequently, 
the slides were incubated for 60 min at room temperature with 
one of the following primary antibodies: rabbit anti-glial 
fibrillary acidic protein (GFAP) (1：500; Dako, Denmark), a 
specific marker of astrocytes, and rabbit anti-Iba1 (1：100; 
Abcam, UK), a marker for microglia. Sections were incubated 
with appropriate peroxidase-linked secondary antibody (1：
200; Santa Cruz Biotechnology, USA) and the immunoreaction 
products were visualized with 3´3-diaminobenzidine (DAB; 
Dako) according to the manufacturer’s instructions. Finally, 
slides were counterstained with hematoxylin, mounted with 
Kaiser gel (Sigma-Aldrich) and examined under a Zeiss 
Axiovert microscope (Carl Zeiss, Germany). 
Western blot analysis
After decapitation, brains were removed from three animals 
and the cortices were dissected and pooled. The selected tissue 
was homogenized with a hand-held pestle in sodium dodecyl 
sulfate (SDS) sample buffer (10 mL/mg) that contained a 
cocktail of proteinase and phosphatase inhibitors [18]. The 
electrophoresis samples were heated at 100oC for 5 min, then 
loaded onto 10% SDS-polyacrylamide gels with standard 
Laemmli solutions (BioRad Laboratories, USA). The proteins 
were electroblotted onto a polyvinylidene difluoride membrane 
(PVDF, Immobilon-P; Millipore, USA), then placed in a 
blocking solution that contained Tris-buffered saline with 
0.02% Tween (TBS-T) and 5% non-fat dry milk for 1 h. Next, 
samples were incubated overnight under gentle agitation with 
primary antibody rabbit anti-GFAP (1：7,000; Dako) and 
mouse anti--actin (1：1,000; Sigma, USA). Bound primary 
antibodies were detected with horseradish peroxidase 
(HRP)-conjugated anti-rabbit secondary antibody (1：5,000; 
Santa Cruz Biotechnology). Between each step, the 
immunoblots were rinsed with TBS-T. Immunoreactive bands 
were visualized on X-ray films (Kodak, USA) using 
chemiluminescence, after which the optical densities of 
immunoreactive bands from four independent blots were 
calculated in the Image Quant program. The densities of GFAP 
and -actin immunoreactive bands were quantified with 
background subtraction. Briefly, squares of identical sizes were 
drawn around each band to measure density, and the 
background near that band was subtracted. For each blot, 
optical densities were normalized against -actin levels.
Statistical analysis
After verifying a normal distribution in all groups using the 
Kolmogorov-Smirnov test, the results were presented as the 
mean ± SEM. The significance of difference between the data 
obtained for different groups was determined by one way 
ANOVA using Dunnett’s C test. Linear regression analysis was 
conducted to determine the relationship between the obtained 
values of parameters using the GraphPad Prism statistical 
program. A p ＜ 0.05 was considered statistically significant. 
Results
The results of our study revealed that CPZ treatment induced 
different changes in parameters of oxidative stress and 
antioxidant capacity in forebrain cortex samples of experimental 
animals. Treatment of rats with AGM (75 mg/kg BW i.p.) alone 
did not significantly affect any of the measured parameters 
relative to those that received only saline. 
CPZ concentration in the rat forebrain cortex
In the CPZ+AGM group, CPZ concentration was 
significantly decreased in the forebrain cortex (p ＜ 0.05) 
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Fig. 1. Tiobarbituric acid reactive substances production (TBARS) concentration (A) and O2•− production (B) in rat forebrain cortex. 
Data are expressed as the means ± SEM. Significant differences between control group (*) and CPZ group (†) were considered (*,†p ＜
0.05, ††p ＜ 0.01, ***,†††p ＜ 0.001, one way ANOVA, Dunnett’s C test).
Table 1. Chlorpromazine (CPZ) concentration in the rat brain 48 
h after appropriate treatment
CPZ concentration (ppm)
CG 1.20 ± 0.61
CPZ 1.80 ± 0.91
CPZ+AGM 1.26 ± 0.45*
AGM 1.38 ± 0.68
CG, control; AGM, agmatine. The data are expressed as the mean ± SEM. 
*Significant difference compared to CPZ group (p ＜ 0.05, One way 
ANOVA, Dunnett’s C test).
Fig. 2. Total glutathione (GSH) content in rat forebrain cortex. 
Data are expressed as the mean ± SEM. Significant differences
between control group (*) and CPZ group (†) were considered 
(*,†p ＜ 0.05, ***,†††p ＜ 0.001, one way ANOVA, Dunnett’s C
test). 
compared to the CPZ group of animals (Table 1). 
Concentrations of parameters of oxidative status in the rat 
forebrain cortex
The concentration of TBARS in the CPZ group increased 
significantly 48 h after treatment in the forebrain cortex (p ＜ 
0.001) compared to the controls (panel A in Fig. 1). Superoxide 
anion production increased significantly in the forebrain cortex 
(p ＜ 0.001) relative to the controls (panel B in Fig. 1). 
Treatment with AGM applied together with CPZ decreased the 
O2•− production in the forebrain cortex (p ＜ 0.05) relative to 
the CPZ group.
In the CPZ group, total GSH content was significantly 
decreased in the forebrain cortex (p ＜ 0.001) compared to the 
controls (Fig. 2). Total GSH content significantly increased in 
both the CPZ+AGM (p ＜ 0.05) and AGM (p ＜ 0.001) groups 
relative to the CPZ group in the forebrain cortex 48 h after 
treatment.
Administration of CPZ resulted in decreased total SOD 
activity (p ＜ 0.001) 48 h after treatment in the forebrain cortex 
relative to the controls (panel A in Fig. 3). In the CPZ+AGM (p 
＜ 0.001) and AGM (p ＜ 0.01) group, total SOD activity 
increased in the forebrain cortex relative to the CPZ-treated 
group. In the CPZ+AGM group, CAT activity was significantly 
incresed in the forebrain cortex (p ＜ 0.05) 48 h after tretment 
relative to the CPZ group (panel B in Fig. 3). 
Administration of CPZ resulted in decreased GPx activity 
(p ＜ 0.05) in the forebrain cortex relative to the controls (panel 
A in Fig. 4). In the CPZ+AGM and AGM group, total GPx 
activity increased (p ＜ 0.001) in the forebrain cortex relative to 
the CPZ-treated group. In the CPZ group, GR activity was 
significantly lower (p ＜ 0.05) in the forebrain cortex compared 
to the control (panel B in Fig. 4) at 48 h. However, GR activity 
increased significantly (p ＜ 0.01) in both the CPZ+AGM and 
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Fig. 3. Total superoxide dismutase (SOD) activity (A) and catalage (CAT) activity (B) in rat forebrain cortex. Data are expressed as the
mean ± SEM. Significant differences between control group (*) and CPZ group (†) were considered (†p ＜ 0.05, ††p ＜ 0.01, ***,†††p
＜ 0.001, one way ANOVA, Dunnett’s C test). 
Fig. 4. Activities of glutathione peroxidase (GPx) (A) and glutathione reductase (GR) (B) in rat forebrain cortex. Data are expressed as
the mean ± SEM. Significant differences between control group (*) and CPZ group (†) were considered (*p ＜ 0.05, ††p ＜ 0.01, †††p
＜ 0.001, one way ANOVA, Dunnett’s C test). 
AGM group in the forebrain cortex relative to CPZ-treated 
animals at 48 h after tretment. 
Correlation Analysis
The results indicate a significant positive correlation (Table 
2) between total SOD activity and CAT activity in the forebrain 
cortex at 48 h after CPZ administration (r = 0.8924, p ＜ 0.01). 
Additonally, a significant negative correlation between CPZ 
concentration with both O2•− level (r = −0.8271, p ＜ 0.05) 
and total GSH concentration (r = −0.9158, p ＜ 0.01) was 
observed. We also found a negative correlation between GR 
activity and TBARS concentration in the forebrain cortex 48 h 
after CPZ treatment (r = −0.8338, p ＜ 0.05) (Table 2).
Immunohistochemistry
In control rats, we observed fibrous astrocytes with small cell 
bodies and long, thin processes of individual astrocytes that 
occupy essentially non-overlapping domains throughout the 
cortex (panel A in Fig. 5). Conversely, 48 h after CPZ 
administration hypertrophy of astrocytes and its proceses 
without substantive loss of individual astrocyte domains was 
observed (panel B in Fig. 5). However, GFAP labelling 
demonstrated a mild reaction in the AGM group (panel D in Fig. 
5), and prominent staining was present in the CPZ+AGM group 
(panel C in Fig. 5).
Staining with Iba1 clearly revealed widespread distribution 
of finely branching microglia and confirmed the essential 
absence of globoid monocytes or macrophages in the CNS 
parenchyma of normal rats (panel A in Fig. 6). In the CPZ group 
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Table 2. Pearson correlation between CPZ concentration, CAT activity and GR activity with other parameters of oxidative status 
(TBARS, O2•−, total GSH and total SOD activity) in the forebrain cortex of the Wistar rats 48 h after CPZ administration
TBARS O2•− tGSH tSOD
CPZ concentration 0.2236 −0.8271* −0.9158** −0.2271
CAT −0.0810 −0.2724 −0.4274 0.8924**
GR −0.8338* −0.0578 −0.5848 −0.3444
Significant difference at *p ＜ 0.05, **p ＜ 0.01, respecively, based on Pearson’s correlation analysis. 
Fig. 5. Representative photomicrographs of glial fibrillary acidic 
protein (GFAP) staining by immunohistochemistry of brain 
sections in the control group (A), CPZ group (B), CPZ+AGM 
group (C) and AGM group (D) 48 h after CPZ administration. Five
rats were tested for each group. 400× (A‒D).
Fig. 6. Representative photomicrographs of Iba1 staining by 
immunohistochemistry of brain sections in the control group (A),
CPZ group (B), CPZ+AGM group (C) and AGM group (D) 48 h
after CPZ administration. Five rats were tested for each group. 
400× (A‒D).
Fig. 7. Quantitative immunoblot detection of GFAP protein 
levels in forebrain cortex isolated from the control, CPZ, 
CPZ+AGM and AGM group 48 h after treatment. Bars represent
the mean GFAP protein abundance (± SEM) from three 
independent determinations expressed relative to -actin. 
Significance is shown in the graph (*p ＜ 0.05 vs. control), which
is accompanied by a representative immunoblot. 
of animals, Iba1 staining confirmed a pronounced increase in 
the number of branched microglia as noted by Iba1 staining in 
both gray and white matter (panel B in Fig. 6). In the 
CPZ+AGM group (panel C in Fig. 6) as well as in the AGM 
group (panel D in Fig. 6), there was a further obvious decrease 
in the number of cells stained with Iba1 relative to the CPZ 
group, with much more widespread distribution of 
Iba1-positive globoid macrophages in the parenchyma.
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Western blot analysis
Immunoblot analysis showed that GFAP was present as a 
single band with a molecular mass of about 50 kDa (Fig. 7). 
There was a significant increase in GFAP expression followed 
CPZ+AGM induced brain injury in rats with respect to 
physiological control and CPZ-induced injury. Moreover, there 
was no increase in GFAP expression relative to the controls 
following AGM. 
Discussion
Our results revealed that oxidative stress plays an important 
role in acute CPZ-induced brain injury in rats. The 
neuroprotective role of AGM could be essential 48 h after 
CPZ-induced neurotoxicity mediated by oxidative stress.
Application of CPZ after 48 h caused no change in the 
concentration of the drug in rat brains relative to the control 
values (Table 1). However, CPZ+AGM significantly reduced 
the concentration of CPZ in the brain, indicating that the 
presence of AGM reduced the resorption of deposited CPZ. 
Application of CPZ+AGM also reduced the distribution of CPZ 
by compartments. Correlation analysis revealed a positive 
correlation between the concentration of CPZ and total SOD 
activity in the forebrain cortex and a negative correlation 
between the concentration of CPZ and both total GSH and O2•− 
production in the forebrain cortex 48 h after CPZ administration.
It is well known that oxidation of membrane lipids results in 
the formation of peroxidation degradation products, which leads 
to cross-linking reactions of the lipid-lipid and lipid- protein type, 
thereby rendering the membrane more rigid and less fluid [22,29]. 
The results of the present study showed that brain TBARS 
concentrations were significantly increased (p ＜ 0.05) in the 
CPZ-treated group relative to the control group in the forebrain 
cortex. Oxidative stress was implicated in tissue damage induced 
by CPZ-treatment [21]. Neurochemical disruption of connectivity 
between the hippocampus and forebrain cortex, as well as the 
striatum induced by CPZ administration could provoke 
retrograde transneuronal damage of the forebrain cortex that 
could explain the increased TBARS concentration observed in 
our experiments. The results of the present study are consistent 
with those of other studies that showed CPZ leads to membrane 
damage through LPO [26,38]. In this study, no change in the 
concentration of TBARS was observed in the forebrain cortex 
after CPZ+AGM administration. Moreover, the cortex contains 
NADPH-dijaforaza-positive neurons, which are resistant to the 
toxic effects of NO. This could explain the security in this region 
of the LPO process [10]. 
Increased O2•− generation in the forebrain cortex after CPZ 
administration indicates temporal and spatial propagation of the 
O2•− production process, since it occurs in the brain structure, 
where there is a suitable biochemical environment for its 
development. Increased production of O2•− after 48 h indicates 
a long-term toxic effect of CPZ because it does not establish a 
redox balance or maintain inadequate AOS. The protective 
effects of the AGM in our study confirmed that the reduced O2•− 
production after CPZ+AGM treatment can be explained by its 
total antioxidant potential.
GSH is a multifunctional, intracellular nonenzymatic 
antioxidant and the major component of intracellular regulation 
of the redox state, providing the first line of defense against 
oxidative injury [27]. GSH is also an important substrate and 
cofactor in drug metabolism. In our study, a decrease in total 
GSH concentration relative to the control group was observed 
48 h after CPZ administration, which could be explained by the 
increased activity of -glutamyltranspeptidase, an enzyme 
localized to the outer surface of the cells, where it breaks down 
extracellular GSH [7]. According to the second explanation, the 
reduction of total GSH is due to increased LPO in the brain, 
which is accompanied by a lack of NADPH required for GR 
activity and transformation of oxidized GSH in the reduced 
form [9]. The increase of total GSH content in the CPZ+AGM 
group shows that AGM prevents oxidative damage by 
increasing the capacity of AOS in the brain tissue of rats. These 
results show the neuroprotective effects of the AGM under 
various pathological conditions, including poisoning [3].
The acute administration of CPZ after 48 h leads to a decrease 
in total SOD activity relative to the control. However, CAT 
activity was equal to the control values 48 h after CPZ 
administration in the forebrain cortex. A positive correlation 
was observed between the activity of SOD and CAT in the 
forebrain cortex 48 h after CPZ administration. The increase in 
LPO and increased O2•− production with a decrease of SOD 
may be associated with an increase in glutamatergic 
transmission following the chronic blockade of dopamine 
receptors. Furthermore, our results show that CPZ+AGM 
reduces O2•− production and increases the activity of the 
antioxidant enzymes SOD and CAT. A study by Schwartz et al. 
[37] showed that SOD and CAT prevented glutamate-induced 
neuronal degeneration.
CPZ reduced the activity of GPx and GR relative to the 
controls and may be a result of disturbance of redox regulatory 
mechanisms in the AOS. Reduced activity of GPx and GR in the 
forebrain cortex shows a loss of total GSH and increased LPO, 
which is also registered in the cortex after CPZ administration. 
Our findings show that GR was negatively correlated with the 
concentration of TBARS in the forebrain cortex 48 h after CPZ 
administration. Treatment with AGM prevents biological 
oxidative damage, while administration of CPZ+AGM 
increases the activity of both GPx and GR, suppresses LPO and 
prevents the development of oxidative stress. 
Astrocytes are integrally involved in metabolic and ionic 
homeostasis, but also generate neurotrophic factors and provide 
neurons with precursors necessary to combat oxidative stress 
[12,36]. It is well known that dysfunction of astrocytes in acute 
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brain injury may compromise neuronal metabolism and 
survival, thereby contributing to neurologic destruction [11]. 
Damage to the extracellular ionic homeostasis maintained by 
astrocytes continues to lead to excitotoxic damage [6]. Acute 
application of CPZ after 48 h led to increased immunoreactivity 
of glial cells in the rat brain in terms of increasing the number of 
GFAP-positive cells. These cells are arranged in non- 
overlapping spatial domains with pronounced hypertrophy of 
cell bodies and processes. We also found an increase in the 
number of GFAP positive cells in the CPZ+AGM group of 
animals. The administration of AGM in CPZ animals, which 
induces a glial reaction resembling reactive astrogliosis with a 
moderate reaction of the GFAP-positive cells, suggests a 
reparative potential of this molecule in the rat brain. 
Based on the electrophoretic profiles of the GFAP molecules 
in the forebrain cortex, we found clear differences in the level of 
expression of the protein, which are most pronounced in the 
CPZ+AGM group of animals 48 h after the treatment. It is well 
known that astrocytes are important producers of antioxidants 
in the normal CNS, and astrocytic production of these 
molecules after brain injury may enhance neuronal survival and 
protect astrocyte function. Therefore, the increased GFAP 
expression may be a contraregulatory mechanism to reduce 
oxidative stress in CPZ+AGM-induced injury.
Reactive astrocytes could have beneficial roles in defense and 
repair, which include suppression of oxidative radicals and the 
LPO process [34]. However, under pathological circumstances, 
glial activation also involves microglia, and their interaction 
with astrocytes may contribute to secondary nerve-cell damage 
[8]. Microglia are innate immune cells residing in the CNS. 
Resting microglia are small cells with long, thin ramified 
processes. Upon activation of microglia, cell bodies become 
enlarged and processes become poorly ramified, short, and 
thick. The brain sections of the control group had few 
Iba1-positive cells with small cell bodies and long, thin ramified 
processes. In CPZ-treated animals, the resting microglia 
became activated, and the number of microglia was significantly 
increased in both white matter and gray matter of the brain 
compared with controls. When rats were treated with 
CPZ+AGM or AGM, there were few Iba1-positive cells in the 
brain, and these Iba1-positive cells had small cell bodies with 
long, thin ramified processes.
The results show that AGM reduces brain levels of oxidative 
stress parameters, improves antioxidant enzymatic and 
non-enzymatic activities, and reduces reactive astrogliosis and 
microglia reactivation in CPZ-induced injury, indicating that 
AGM might exert a protective effect against brain damage.
Acknowledgments
This work was supported by the Ministry of Education, Science 
and Technological Development of the Republic of Serbia, 
project No. III41014 and by the Military Medical Academy, 
projects Nos. МВМА/3/13-15 and МВМА/6/15-17. 
Conflict of Interest
There is no conflict of interest.
References
1. Ahmed Z, Shaw G, Sharma VP, Yang C, McGowan E, 
Dickson DW. Actin-binding proteins coronin-1a and IBA-1 
are effective microglial markers for immunohistochemistry. 
J Histochem Cytochem 2007, 55, 687-700. 
2. Anderson ME. The DTNB-GSSG reductase recycling assay 
for total glutathione (GSH + 1/2 GSSG). In: Greenwald RA 
(ed.). CRC Handbook of Methods for Oxygen Radical 
Research. pp. 319-323, CRC Press, Boca Raton, 1985.
3. Atif F, Yousuf S, Agrawal SK. Restraint stress-induced 
oxidative damage and its amelioration with selenium. Eur J 
Pharmacol 2008, 600, 59-63.
4. Auclair C, Voisin E. Nitroblue tetrazolium reduction. In: 
Greenwald RA (ed.). CRC Handbook of Methods for 
Oxygen Radical Research. pp. 123-132, CRC Press, Boca 
Raton, 1985.
5. Balijepalli S, Kenchappa RS, Boyd MR, Ravindranath V. 
Protein thiol oxidation by haloperidol results in inhibition of 
mitochondrial complex I in brain regions: comparison with 
atypical antipsychotics. Neurochem Int 2001, 38, 425-435.
6. Barreto G, White RE, Ouyang Y, Xu L, Giffard RG. 
Astrocytes: targets for neuroprotection in stroke. Cent Nerv 
Syst Agents Med Chem 2011, 11, 164-173.
7. Carvalho M, Hawksworth G, Milhazes N, Borges F, Monks 
TJ, Fernandes E, Carvalho F, Bastos M. Role of metabolites 
in MDMA (ecstasy)-induced nephrotoxicity: an in vitro 
study using rat and human renal proximal tubular cells. Arch 
Toxicol 2002, 76, 581-588. 
8. Chastain EM, Duncan DS, Rodgers JM, Miller SD. The role 
of antigen presenting cells in multiple sclerosis. Biochim 
Biophys Acta 2011, 1812, 265-274.
9. Deneke SM. Thiol-based antioxidants. Curr Top Cell Regul 
2000, 36, 151-180.
10. DiCiero Miranda M, de Bruin VMS, Vale MR, Viana GSB. 
Lipid peroxidation and nitrite plus nitrate levels in brain 
tissue from patients with Alzheimer's disease. Gerontology 
2000, 46, 179-184.
11. Dienel GA, Hertz L. Glucose and lactate metabolism during 
brain activation. J Neurosci Res 2001, 66, 824-838.
12. Fernandez-Fernandez S, Almeida A, Bolaños JP. Antioxidant 
and bioenergetic coupling between neurons and astrocytes. 
Biochem J 2012, 443, 3-11.
13. Freifelder D. Zonal centrifugation. Methods Enzymol 1973, 
27, 140-150.
14. Furuno T, Kanno T, Arita K, Asami M, Utsumi T, Doi Y, 
Inoue M, Utsumi K. Roles of long chain fatty acids and 
carnitine in mitochondrial membrane permeability 
transition. Biochem Pharmacol 2001, 62, 1037-1046.
15. Girotti MJ, Khan N, McLellan BA. Early measurement of 
Chlorpromazine brain toxicity    61
www.vetsci.org
systemic lipid peroxidation products in the plasma of major 
blunt trauma patients. J Trauma 1991, 31, 32-35.
16. Góth L. A simple method for determination of serum 
catalase activity and revision of reference range. Clin Chim 
Acta 1991, 196, 143-151.
17. Gurd JW, Jones LR, Mahler HR, Moore WJ. Isolation and 
partial characterization of rat brain synaptic membranes. J 
Neurochem 1974, 22, 281-290.
18. Harry GJ, Schmitt TJ, Gong Z, Brown H, Zawia N, Evans 
HL. Lead-induced alterations of glial fibrillary acidic 
protein (GFAP) in the developing rat brain. Toxicol Appl 
Pharmacol 1996, 139, 84-93.
19. Heitzman RJ, Hibbitt KG, Mather I. Changes in hormone 
and metabolites concentrations in the blood of cows during 
the experimental induction of ketosis. Br Vet J 1972, 128, 
347-354.
20. Kawai Y, Smedsrød B, Elvevold K, Wake K. Uptake of 
lithium carmine by sinusoidal endothelial and Kupffer cells 
of the rat liver: new insights into the classical vital staining 
and the reticulo-endothelial system. Cell Tissue Res 1998, 
292, 395-410.
21. Khatua AK, Bhattacharyya M. NADPH-induced oxidative 
damage of rat liver microsomes: protective role of 
chlorpromazine and trifluoperazine. Pol J Pharmacol 2001, 
53, 629-634.
22. Levin G, Cogan U, Mokady S. Riboflavin deficiency and the 
function and fluidity of rat erythrocyte membranes. J Nutr 
1990, 120, 857-861.
23. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein 
measurement with the folin phenol reagent. J Biol Chem 
1951, 193, 265-275.
24. Magliozzi R, Howell OW, Reeves C, Roncaroli F, Nicholas 
R, Serafini B, Aloisi F, Reynolds R. A gradient of neuronal 
loss and meningeal inflammation in multiple sclerosis. Ann 
Neurol 2010, 68, 477-493.
25. Makarov VA, Petrukhina GN, Remov MN, Miftakhova NT, 
Kuz’mich MK, Popov VG. Effect of combined 
administration of acetylsalicylic acid and antioxidants on 
cellular and plasma hemostasis. Eksp Klin Farmakol 2002, 
65, 32-36.
26. Naidu PS, Singh A, Kulkarni SK. Carvedilol attenuates 
neuroleptic-induced orofacial dyskinesia: possible 
antioxidant mechanisms. Br J Pharmacol 2002, 136, 
193-200.
27. Nemmiche S, Chabane-Sari D, Kadri M, Guiraud P. 
Cadmium-induced apoptosis in the BJAB human B cell line: 
involvement of PKC/ERK1/2/JNK signaling pathways in 
HO-1 expression. Toxicology 2012, 300, 103-111. 
28. Nicotera P, Bellomo G, Orrenius S. The role of Ca2+ in cell 
killing. Chem Res Toxicol 1990, 3, 484-494.
29. Ohyashiki T, Sakata N, Matsui K. Decrease of lipid fluidity 
of the porcine intestinal brush-border membranes by 
treatment with malondialdehyde. J Biochem 1992, 111, 
419-423.
30. Parikh V, Khan MM, Mahadik SP. Differential effects of 
antipsychotics on expression of antioxidant enzymes and 
membrane lipid peroxidation in rat brain. J Psychiatr Res 
2003, 37, 43-51.
31. Patel MX, Arista IA, Taylor M, Barnes TRE. How to 
compare doses of different antipsychotics: a systematic 
review of methods. Schizophr Res 2013, 149, 141-148. 
32. Piletz JE, Aricioglu F, Cheng JT, Fairbanks CA, Gilad VH, 
Haenisch B, Halaris A, Hong S, Lee JE, Li J, Liu P, 
Molderings GJ, Rodrigues ALS, Satriano J, Seong GJ, 
Wilcox G, Wu N, Gilad GM. Agmatine: clinical applications 
after 100 years in translation. Drug Discov Today 2013, 18, 
880-893. 
33. Reddy RD, Yao JK. Free radical pathology in schizophrenia: 
a review. Prostaglandins Leukot Essent Fatty Acids 1996, 
55, 33-43.
34. Röhl C, Armbrust E, Herbst E, Jess A, Gülden M, Maser E, 
Rimbach G, Bösch-Saadatmandi C. Mechanisms involved 
in the modulation of astroglial resistance to oxidative stress 
induced by activated microglia: antioxidative systems, 
peroxide elimination, radical generation, lipid peroxidation. 
Neurotox Res 2010, 17, 317-331.
35. Rushaidhi M, Zhang H, Liu P. Effects of prolonged agmatine 
treatment in aged male Sprague-Dawley rats. Neuroscience 
2013, 234, 116-124. 
36. Schubert P, Ogata T, Marchini C, Ferroni S. Glia-related 
pathomechanisms in Alzheimer’s disease: a therapeutic 
target? Mech Ageing Dev 2001, 123, 47-57.
37. Schwartz PJ, Reaume A, Scott R, Coyle JT. Effects of over- 
and under-expression of Cu,Zn-superoxide dismutase on the 
toxicity of glutamate analogs in transgenic mouse striatum. 
Brain Res 1998, 789, 32-39.
38. Sulaiman AA, Al-Shawi NN, Jwaied AH, Mahmood DM, 
Hussain SA. Protective effect of melatonin against 
chlorpromazine-induced liver disease in rats. Saudi Med J 
2006, 27, 1477-1482.
39. Sun M, Zigman S. An improved spectrophotometric assay 
for superoxide dismutase based on epinephrine autoxidation. 
Anal Biochem 1978, 90, 81-89.
40. Todorova K, Ivanov S, Genova M. Selenium and glutathion 
peroxidase enzyme levels in diabetic patients with early 
spontaneous abortions. Akush Ginekol (Sofiia) 2006, 45, 
3-9.
